ONIT Sciences is expanding its reach with product registration efforts underway in Canada and Oregon. ONIT Grow is currently being tested at farms and cooperatives in Alberta, Saskatchewan, Manitoba and British Columbia. Registration in Oregon is driven by request from a grower who realized exceptional results from multiple field trials of ONIT Grow and is now interested in forming a distributorship. “Registration is an exercise in building value,” stated ONIT Sciences’ Chief Operating Officer, Dennis Locke. “Some states or countries make the process very easy. Canada and Oregon are both significantly more challenging than most. We submitted multiple samples to Canada for testing, all from different production runs. This ensures consistency regarding stated ingredients. We expect to receive confirmation within the next 30 days from Canada with Oregon to follow.” ONIT Sciences’ subsidiary, ONIT Sciences Canada, has been very active with its field trials campaign, attracting interest from some of the largest farming cooperatives in the country’s heartland. The office supports multiple sales representatives throughout the major farming territories and expects to see purchase orders coincide with acceptance of product registration.
About ONIT Sciences
ONIT Sciences is an agriculture technology company. ONIT’s name is an acronym that describes the company’s unique approach to the industry: Organic Natural Input Technology. It is the company’s mission to increase plant health and crop yield through natural, organic, non-GMO sciences while maximizing value to customers, shareholders, partners and employees. Established in 2018, the company is led by industry veterans and maintains offices in Irvine, California.
Call ONIT Sciences at (949) 317-1811 now to find out how you can participate in the tremendous upside potential of the medical cannabis market—while avoiding regulatory hurdles faced by growers, processors and retailers.
The information set forth herein is presented for informational purposes only and should not be deemed an offer to sell securities. This presentation contains information which the Company believes to be correct, including certain financial information and projections, but the Company does not guarantee as to the accuracy or completeness of such information. The Company reserves the right to modify or amend the information contained herein.